LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) will host the Aldeyra 2024 Research & Development Day with investors and financial analysts in New York City to present recent pipeline developments relating to …
Harrow Will Release First Quarter 2024 Financial Results After Market Close on May 13, 2024
NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced that it will release its financial results for the first quarter ended March 31, 2024, on Monday, May 13, 2024, after the…
SCIENCE CORPORATION ACQUIERT L’IMPLANT RÉTINAL PRIMA DE PIXIUM, RENFORÇANT ET DIVERSIFIANT AINSI SON ENGAGEMENT EN FAVEUR DE LA RESTAURATION DE LA VISION GRÂCE À SA TECHNOLOGIE D'INTERFACE NEURONALE DIRECTE
ALAMEDA, CALIFORNIE–(BUSINESS WIRE)–Science Corporation (« Science »), leader de la technologie d’interface neuronale directe (« IND ») et développeur de Science Eye, a fait l’acquisition des droits de PI et des actifs associés pour l’implant rétinie…
Science Corporation Acquires Pixium’s PRIMA Retinal Implant, Extending and Diversifying Its Commitment to Vision Restoration Through Brain-Computer Interface Technology
ALAMEDA, Calif.–(BUSINESS WIRE)–Science Corporation acquires Pixium’s PRIMA retinal implant, diversifying commitment to vision restoration
BrightFocus Foundation Announces $10M in New Funding Across Brain and Vision Research, Celebrates Historic Diversity of Grant Award Recipients
CLARKSBURG, Md.–(BUSINESS WIRE)–Global nonprofit BrightFocus Foundation announces $10 million in new Alzheimer’s disease, macular degeneration, and glaucoma research grant funding—age-related diseases with no cure that affect more than 335 million pe…
ASCRS 2024: Healio’s top items so far
As Healio’s coverage of the American Society of Cataract and Refractive Surgery meeting continues, take a look at the most popular articles and videos so far.Topics from the meeting include the evolutionary mindset of refractive surgery and a discussio…